X-COR Therapeutics
Student i-lab
X-COR Therapeutics
Creating the first commercially-available extracorporeal CO2 removal device that uses ultra-low-blood flow to treat patients with hypercarbic respiratory failure.
About X-COR Therapeutics
School
Harvard Medical School, Harvard Business School
Lab
Connect
Awards & Affiliations
Join Us
Current Harvard students: submit your spring membership form by Thursday, January 9.
